Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 1
1954 11
1955 20
1956 15
1957 5
1958 5
1959 6
1960 7
1961 6
1962 2
1963 2
1964 14
1965 8
1966 15
1967 17
1968 13
1969 17
1970 19
1971 18
1972 32
1973 20
1974 14
1975 19
1976 20
1977 20
1978 18
1979 10
1980 30
1981 22
1982 23
1983 16
1984 17
1985 16
1986 13
1987 12
1988 20
1989 13
1990 9
1991 12
1992 18
1993 14
1994 7
1995 7
1996 6
1997 9
1998 5
1999 5
2000 6
2001 9
2002 9
2003 13
2004 8
2005 11
2006 11
2007 12
2008 12
2009 10
2010 10
2011 6
2012 21
2013 11
2014 13
2015 10
2016 13
2017 20
2018 11
2019 10
2020 10
2021 11
2022 17
2023 7
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

886 results

Results by year

Filters applied: . Clear all
Page 1
Pseudo-resistance to anticancer drugs.
Davoli E, Zucchetti M, Giavazzi R, Garattini S, Frapolli R. Davoli E, et al. Among authors: garattini s. Ther Adv Med Oncol. 2022 Nov 14;14:17588359221136776. doi: 10.1177/17588359221136776. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36407785 Free PMC article. No abstract available.
Noninferiority Trials.
Garattini S, Bertele’ V. Garattini S, et al. N Engl J Med. 2018 Jan 18;378(3):303. doi: 10.1056/NEJMc1714668. N Engl J Med. 2018. PMID: 29345450 No abstract available.
Disappointing biotech.
Joppi R, Bertele' V, Garattini S. Joppi R, et al. Among authors: garattini s. BMJ. 2005 Oct 15;331(7521):895-7. doi: 10.1136/bmj.331.7521.895. BMJ. 2005. PMID: 16223825 Free PMC article. Review.
How can we regulate medicines better?
Garattini S, Bertele' V. Garattini S, et al. BMJ. 2007 Oct 20;335(7624):803-5. doi: 10.1136/bmj.39281.615706.94. BMJ. 2007. PMID: 17947785 Free PMC article. Review.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.
Rimini M, Masi G, Lonardi S, Nichetti F, Pressiani T, Lavacchi D, Jessica L, Giordano G, Scartozzi M, Tamburini E, Pastorino A, Rapposelli IG, Daniele B, Martinelli E, Garajova I, Aprile G, Schirripa M, Formica V, Salani F, Winchler C, Bergamo F, Balsano R, Gusmaroli E, Lorenzo A, Landriscina M, Pretta A, Toma I, Pirrone C, Diana A, Leone F, Brunetti O, Brandi G, Garattini SK, Satolli MA, Rossari F, Fornaro L, Niger M, Zanuso V, De Rosa A, Ratti F, Aldrighetti L, De Braud F, Foti S, Rizzato MD, Vivaldi C, Stefano C, Rimassa L, Antonuzzo L, Casadei-Gardini A. Rimini M, et al. Among authors: garattini sk. Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1. Target Oncol. 2024. PMID: 38691295
Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms.
Guarrera L, Kurosaki M, Garattini SK, Gianni' M, Fasola G, Rossit L, Prisciandaro M, Di Bartolomeo M, Bolis M, Rizzo P, Nastasi C, Foglia M, Zanetti A, Paroni G, Terao M, Garattini E. Guarrera L, et al. Among authors: garattini sk. J Exp Clin Cancer Res. 2023 Nov 11;42(1):298. doi: 10.1186/s13046-023-02869-w. J Exp Clin Cancer Res. 2023. PMID: 37951921 Free PMC article.
Conditional approval of medicines by the EMA.
Banzi R, Gerardi C, Bertele' V, Garattini S. Banzi R, et al. Among authors: garattini s. BMJ. 2017 May 2;357:j2062. doi: 10.1136/bmj.j2062. BMJ. 2017. PMID: 28465401 No abstract available.
Controlling cervical cancer.
Bonati M, Garattini S. Bonati M, et al. Among authors: garattini s. Pharmacoeconomics. 2009;27(2):91-3. doi: 10.2165/00019053-200927020-00001. Pharmacoeconomics. 2009. PMID: 19254043 No abstract available.
Anything new in EU pharmacovigilance?
Garattini S, Bertele' V. Garattini S, et al. Eur J Clin Pharmacol. 2011 Nov;67(11):1199-200. doi: 10.1007/s00228-011-1052-1. Epub 2011 May 4. Eur J Clin Pharmacol. 2011. PMID: 21541780 No abstract available.
886 results